Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (241-250 of 380) with videos related to

Pageof 38
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cellsM Limonta, A Biondi, G Giudici, et al.
Blood|April 1, 1989
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemiaA Biondi, V Rossi, R Bassan, et al.
European Journal of Haematology|August 1, 1990
Cancer procoagulant in acute lymphoblastic leukemiaM G Alessio, A Falanga, R Consonni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI)S Cortelazzo, A Rossi, P Bellavita, et al.
Blood|August 15, 1989
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndromeP M Mannucci, R Lombardi, A Lattuada, et al.
British Journal of Haematology|July 1, 1990
Duration of first remission in leukaemic recipients of leucocyte-poor blood componentsP Rebulla, M Pappalettera, T Barbui, et al.
Blood|November 24, 2001
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59J Golay, M Lazzari, V Facchinetti, et al.
Haematologica|June 22, 2001
Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplantG Dotti, A Rambaldi, R Fiocchi, et al.
Blood|February 1, 1997
Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cellsM Gianni, M Terao, I Fortino, et al.
Thrombosis and Haemostasis|April 1, 1995
Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutationH Ireland, T Bayston, E Thompson, et al.
Pageof 38

Showing results (241-250 of 380) with videos related to

Sort By:
Pageof 38
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cellsM Limonta, A Biondi, G Giudici, et al.
Blood|April 1, 1989
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemiaA Biondi, V Rossi, R Bassan, et al.
European Journal of Haematology|August 1, 1990
Cancer procoagulant in acute lymphoblastic leukemiaM G Alessio, A Falanga, R Consonni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI)S Cortelazzo, A Rossi, P Bellavita, et al.
Blood|August 15, 1989
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndromeP M Mannucci, R Lombardi, A Lattuada, et al.
British Journal of Haematology|July 1, 1990
Duration of first remission in leukaemic recipients of leucocyte-poor blood componentsP Rebulla, M Pappalettera, T Barbui, et al.
Blood|November 24, 2001
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59J Golay, M Lazzari, V Facchinetti, et al.
Haematologica|June 22, 2001
Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplantG Dotti, A Rambaldi, R Fiocchi, et al.
Blood|February 1, 1997
Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cellsM Gianni, M Terao, I Fortino, et al.
Thrombosis and Haemostasis|April 1, 1995
Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutationH Ireland, T Bayston, E Thompson, et al.
Pageof 38